Details
Stereochemistry | ACHIRAL |
Molecular Formula | 5Al.10Mg.2O4S.31HO.H2O |
Molecular Weight | 1115.326 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
O.[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[Mg++].[Mg++].[Mg++].[Mg++].[Mg++].[Mg++].[Mg++].[Mg++].[Mg++].[Mg++].[Al+3].[Al+3].[Al+3].[Al+3].[Al+3].[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O
InChI
InChIKey=SPPNVMTVMQOKSC-UHFFFAOYSA-A
InChI=1S/5Al.10Mg.2H2O4S.32H2O/c;;;;;;;;;;;;;;;2*1-5(2,3)4;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;/h;;;;;;;;;;;;;;;2*(H2,1,2,3,4);32*1H2/q5*+3;10*+2;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;/p-35
Molecular Formula | Al |
Molecular Weight | 26.9815 |
Charge | 3 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Molecular Formula | HO4S |
Molecular Weight | 97.071 |
Charge | -1 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Molecular Formula | HO |
Molecular Weight | 17.0073 |
Charge | -1 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Molecular Formula | Mg |
Molecular Weight | 24.305 |
Charge | 2 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Primary | ZANTANOL Approved UseHelps relieve symptoms associated with indigestion: pain in the upper abdomen, heartburn, indigestion, nausea. |
|||
Primary | ZANTANOL Approved UseHelps relieve symptoms associated with indigestion: pain in the upper abdomen, heartburn, indigestion, nausea. |
|||
Primary | ZANTANOL Approved UseHelps relieve symptoms associated with indigestion: pain in the upper abdomen, heartburn, indigestion, nausea. |
|||
Primary | ZANTANOL Approved UseHelps relieve symptoms associated with indigestion: pain in the upper abdomen, heartburn, indigestion, nausea. |
|||
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 18:29:21 GMT 2023
by
admin
on
Fri Dec 15 18:29:21 GMT 2023
|
Record UNII |
6V88E24N5T
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
WHO-VATC |
QA02AF01
Created by
admin on Fri Dec 15 18:29:21 GMT 2023 , Edited by admin on Fri Dec 15 18:29:21 GMT 2023
|
||
|
CFR |
21 CFR 331.11
Created by
admin on Fri Dec 15 18:29:21 GMT 2023 , Edited by admin on Fri Dec 15 18:29:21 GMT 2023
|
||
|
WHO-ATC |
A02AD02
Created by
admin on Fri Dec 15 18:29:21 GMT 2023 , Edited by admin on Fri Dec 15 18:29:21 GMT 2023
|
||
|
WHO-ATC |
A02AF01
Created by
admin on Fri Dec 15 18:29:21 GMT 2023 , Edited by admin on Fri Dec 15 18:29:21 GMT 2023
|
||
|
CFR |
21 CFR 331.15
Created by
admin on Fri Dec 15 18:29:21 GMT 2023 , Edited by admin on Fri Dec 15 18:29:21 GMT 2023
|
||
|
WHO-VATC |
QA02AD02
Created by
admin on Fri Dec 15 18:29:21 GMT 2023 , Edited by admin on Fri Dec 15 18:29:21 GMT 2023
|
||
|
NCI_THESAURUS |
C29701
Created by
admin on Fri Dec 15 18:29:21 GMT 2023 , Edited by admin on Fri Dec 15 18:29:21 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
6V88E24N5T
Created by
admin on Fri Dec 15 18:29:21 GMT 2023 , Edited by admin on Fri Dec 15 18:29:21 GMT 2023
|
PRIMARY | |||
|
4416
Created by
admin on Fri Dec 15 18:29:21 GMT 2023 , Edited by admin on Fri Dec 15 18:29:21 GMT 2023
|
PRIMARY | |||
|
DB08938
Created by
admin on Fri Dec 15 18:29:21 GMT 2023 , Edited by admin on Fri Dec 15 18:29:21 GMT 2023
|
PRIMARY | |||
|
4926
Created by
admin on Fri Dec 15 18:29:21 GMT 2023 , Edited by admin on Fri Dec 15 18:29:21 GMT 2023
|
PRIMARY | |||
|
C016545
Created by
admin on Fri Dec 15 18:29:21 GMT 2023 , Edited by admin on Fri Dec 15 18:29:21 GMT 2023
|
PRIMARY | |||
|
1374000
Created by
admin on Fri Dec 15 18:29:21 GMT 2023 , Edited by admin on Fri Dec 15 18:29:21 GMT 2023
|
PRIMARY | |||
|
6V88E24N5T
Created by
admin on Fri Dec 15 18:29:21 GMT 2023 , Edited by admin on Fri Dec 15 18:29:21 GMT 2023
|
PRIMARY | |||
|
29151
Created by
admin on Fri Dec 15 18:29:21 GMT 2023 , Edited by admin on Fri Dec 15 18:29:21 GMT 2023
|
PRIMARY | RxNorm | ||
|
SUB08636MIG
Created by
admin on Fri Dec 15 18:29:21 GMT 2023 , Edited by admin on Fri Dec 15 18:29:21 GMT 2023
|
PRIMARY | |||
|
MAGALDRATE
Created by
admin on Fri Dec 15 18:29:21 GMT 2023 , Edited by admin on Fri Dec 15 18:29:21 GMT 2023
|
PRIMARY | |||
|
m6984
Created by
admin on Fri Dec 15 18:29:21 GMT 2023 , Edited by admin on Fri Dec 15 18:29:21 GMT 2023
|
PRIMARY | Merck Index | ||
|
C95958
Created by
admin on Fri Dec 15 18:29:21 GMT 2023 , Edited by admin on Fri Dec 15 18:29:21 GMT 2023
|
PRIMARY | |||
|
122706784
Created by
admin on Fri Dec 15 18:29:21 GMT 2023 , Edited by admin on Fri Dec 15 18:29:21 GMT 2023
|
PRIMARY | |||
|
74978-16-8
Created by
admin on Fri Dec 15 18:29:21 GMT 2023 , Edited by admin on Fri Dec 15 18:29:21 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ANHYDROUS->SOLVATE |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |